Thórir Einarsson Long

8PUBLICATIONS
27CO-AUTHORS
Medical mycologyImmunogenetics (incl. genetic immunology)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.

|Mar 30, 2026
Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.

Lærke Sloth Andersen, Cecilie Velsø Mæng, Sæmundur Rögnvaldsson

|Apr 28, 2025
Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis.

Cecilie Velsoe Maeng, Sæmundur Rögnvaldsson, Thórir Einarsson Long

|Dec 19, 2024
Approaching hypercalcemia in monoclonal gammopathy of undetermined significance: insights from the iStopMM screening study.

Ástrún Helga Jónsdóttir, Helga Ágústa Sigurjónsdóttir, Sigrun Thorsteinsdóttir

|Dec 18, 2024
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study.

Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir

|May 20, 2024
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.

Ingigerdur Sverrisdottir, Sigrun Thorsteinsdottir, Sæmundur Rognvaldsson

Pageof 2

Frequent Collaborators

9 joint publications

Sigrún Thorsteinsdóttir

8 joint publications

Sigurdur Yngvi Kristinsson

7 joint publications

Sæmundur Rögnvaldsson

5 joint publications

Malin Hultcrantz